154 related articles for article (PubMed ID: 38508786)
1. FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
Cengel KA; Kim MM; Diffenderfer ES; Busch TM
Semin Radiat Oncol; 2024 Apr; 34(2):218-228. PubMed ID: 38508786
[TBL] [Abstract][Full Text] [Related]
2. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
[TBL] [Abstract][Full Text] [Related]
3. FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response.
Velalopoulou A; Karagounis IV; Cramer GM; Kim MM; Skoufos G; Goia D; Hagan S; Verginadis II; Shoniyozov K; Chiango J; Cerullo M; Varner K; Yao L; Qin L; Hatzigeorgiou AG; Minn AJ; Putt M; Lanza M; Assenmacher CA; Radaelli E; Huck J; Diffenderfer E; Dong L; Metz J; Koumenis C; Cengel KA; Maity A; Busch TM
Cancer Res; 2021 Sep; 81(18):4808-4821. PubMed ID: 34321243
[TBL] [Abstract][Full Text] [Related]
4. Understanding the FLASH effect to unravel the potential of ultra-high dose rate irradiation.
Kacem H; Almeida A; Cherbuin N; Vozenin MC
Int J Radiat Biol; 2022; 98(3):506-516. PubMed ID: 34788193
[TBL] [Abstract][Full Text] [Related]
5. Technical note: A small animal irradiation platform for investigating the dependence of the FLASH effect on electron beam parameters.
Byrne KE; Poirier Y; Xu J; Gerry A; Foley MJ; Jackson IL; Sawant A; Jiang K
Med Phys; 2024 Feb; 51(2):1421-1432. PubMed ID: 38207016
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Tumor Control and Skin Damage in a Mouse Model after Ultra-High Dose Rate Irradiation and Conventional Irradiation.
Duval KEA; Aulwes E; Zhang R; Rahman M; Ashraf MR; Sloop A; Sunnerberg J; Williams BB; Cao X; Bruza P; Kheirollah A; Tavakkoli A; Jarvis LA; Schaner PE; Swartz HM; Gladstone DJ; Pogue BW; Hoopes PJ
Radiat Res; 2023 Sep; 200(3):223-231. PubMed ID: 37590482
[TBL] [Abstract][Full Text] [Related]
7. Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps.
Zou W; Zhang R; Schüler E; Taylor PA; Mascia AE; Diffenderfer ES; Zhao T; Ayan AS; Sharma M; Yu SJ; Lu W; Bosch WR; Tsien C; Surucu M; Pollard-Larkin JM; Schuemann J; Moros EG; Bazalova-Carter M; Gladstone DJ; Li H; Simone CB; Petersson K; Kry SF; Maity A; Loo BW; Dong L; Maxim PG; Xiao Y; Buchsbaum JC
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1202-1217. PubMed ID: 37121362
[TBL] [Abstract][Full Text] [Related]
8. Ultra-high dose rate dosimetry: Challenges and opportunities for FLASH radiation therapy.
Romano F; Bailat C; Jorge PG; Lerch MLF; Darafsheh A
Med Phys; 2022 Jul; 49(7):4912-4932. PubMed ID: 35404484
[TBL] [Abstract][Full Text] [Related]
9. A simulation study of ionizing radiation acoustic imaging (iRAI) as a real-time dosimetric technique for ultra-high dose rate radiotherapy (UHDR-RT).
Ba Sunbul NH; Zhang W; Oraiqat I; Litzenberg DW; Lam KL; Cuneo K; Moran JM; Carson PL; Wang X; Clarke SD; Matuszak MM; Pozzi SA; El Naqa I
Med Phys; 2021 Oct; 48(10):6137-6151. PubMed ID: 34431520
[TBL] [Abstract][Full Text] [Related]
10. FLASH radiotherapy treatment planning and models for electron beams.
Rahman M; Trigilio A; Franciosini G; Moeckli R; Zhang R; Böhlen TT
Radiother Oncol; 2022 Oct; 175():210-221. PubMed ID: 35964763
[TBL] [Abstract][Full Text] [Related]
11. Dose and dose rate dependence of the tissue sparing effect at ultra-high dose rate studied for proton and electron beams using the zebrafish embryo model.
Horst F; Bodenstein E; Brand M; Hans S; Karsch L; Lessmann E; Löck S; Schürer M; Pawelke J; Beyreuther E
Radiother Oncol; 2024 May; 194():110197. PubMed ID: 38447870
[TBL] [Abstract][Full Text] [Related]
12. Radiobiological Aspects of FLASH Radiotherapy.
Hageman E; Che PP; Dahele M; Slotman BJ; Sminia P
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291585
[TBL] [Abstract][Full Text] [Related]
13. FLASH radiotherapy with carbon ion beams.
Weber UA; Scifoni E; Durante M
Med Phys; 2022 Mar; 49(3):1974-1992. PubMed ID: 34318508
[TBL] [Abstract][Full Text] [Related]
14. The DRESDEN PLATFORM is a research hub for ultra-high dose rate radiobiology.
Metzkes-Ng J; Brack FE; Kroll F; Bernert C; Bock S; Bodenstein E; Brand M; Cowan TE; Gebhardt R; Hans S; Helbig U; Horst F; Jansen J; Kraft SD; Krause M; Leßmann E; Löck S; Pawelke J; Püschel T; Reimold M; Rehwald M; Richter C; Schlenvoigt HP; Schramm U; Schürer M; Seco J; Szabó ER; Umlandt MEP; Zeil K; Ziegler T; Beyreuther E
Sci Rep; 2023 Nov; 13(1):20611. PubMed ID: 37996453
[TBL] [Abstract][Full Text] [Related]
15. FLASH radiotherapy sparing effect on the circulating lymphocytes in pencil beam scanning proton therapy: impact of hypofractionation and dose rate.
Galts A; Hammi A
Phys Med Biol; 2024 Jan; 69(2):. PubMed ID: 38081067
[No Abstract] [Full Text] [Related]
16. FLASH radiotherapy with photon beams.
Montay-Gruel P; Corde S; Laissue JA; Bazalova-Carter M
Med Phys; 2022 Mar; 49(3):2055-2067. PubMed ID: 34519042
[TBL] [Abstract][Full Text] [Related]
17. FLASH ultra-high dose rates in radiotherapy: preclinical and radiobiological evidence.
Borghini A; Vecoli C; Labate L; Panetta D; Andreassi MG; Gizzi LA
Int J Radiat Biol; 2022; 98(2):127-135. PubMed ID: 34913413
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of intensity-modulated electron FLASH radiotherapy in a clinical setting using veterinary cases.
Konradsson E; Szecsenyi RE; Adrian G; Coskun M; Børresen B; Arendt ML; Erhart K; Bäck SÅ; Petersson K; Ceberg C
Med Phys; 2023 Oct; 50(10):6569-6579. PubMed ID: 37696040
[TBL] [Abstract][Full Text] [Related]
19. Ultra-high dose rate radiation production and delivery systems intended for FLASH.
Farr J; Grilj V; Malka V; Sudharsan S; Schippers M
Med Phys; 2022 Jul; 49(7):4875-4911. PubMed ID: 35403262
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.
Montay-Gruel P; Acharya MM; Gonçalves Jorge P; Petit B; Petridis IG; Fuchs P; Leavitt R; Petersson K; Gondré M; Ollivier J; Moeckli R; Bochud F; Bailat C; Bourhis J; Germond JF; Limoli CL; Vozenin MC
Clin Cancer Res; 2021 Feb; 27(3):775-784. PubMed ID: 33060122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
